Δευτέρα 18 Φεβρουαρίου 2019

Incidence, root causes, and outcomes of surgical site infections in a tertiary care hospital in Rwanda: a prospective observational cohort study

Abstract

Background

Surgical Site Infections (SSI) are the most reported health acquired infection and common surgical complication in both developed and developing countries. In developing countries such as Rwanda, there is a paucity of published reports on the pattern of SSI, therefore this study aimed at assessing the incidence, risk factors and the antibiotic profile of pathogens responsible of SSI.

Methods

This prospective study included 294 patients admitted between October 10, 2017 and February 12, 2018 to the surgical department of the University Teaching Hospital of Kigali. Patients data were collected using a structured and pretested questionnaire in English version. Regular follow-up was maintained until at least 30 days postoperatively. Samples were collected from suspected wounds and identified using different bacteria culture media. Data were analyzed using Statistical Package for the Social Sciences (SPSS) software word version 20.0. P-value < 0.05 was considered statistically significant.

Results

The overall incidence of SSI was 10.9%. The associated risk factors were found to be an increased age, ASA class, wound classification, skills and experience of the surgeon, longer duration of surgery (> 2 h), prolonged duration of hospital stay, blood transfusion and emergency surgery. The most common pathogens isolated were Klebsiella ssp (55%), followed by Escherichia coli (15%) and Proteus ssp (12%), Acinectobacter (9%), Staphylococcus aureus (6%) and coagulase-negative staphylococci (3%).The pathogens revealed different levels of antibiotic resistance; amoxy-clavilinic acid (98.8%), gentamicin (92.6%), ciprofloxacin (78.1%) and ceftriaxone (53.3%). On the other hand, Amikacin and imipinem were the only two most effective antibiotics for all isolated pathogens with 100% sensitivity.

Conclusion

SSI incidence rate was revealed to be within acceptable international ranges. However, multi drug resistance was seen in half of the isolates leaving clinicians with few choices of drugs for the treatment of patients with SSI. Periodic surveillance of bacteria and antibiotic susceptibility coupled with the implementation of strict protocol for antibiotic administration and operative room regulations are important to minimize the burden of SSI with resistant bacteria pathogens.



http://link.springer.com/10.1186/s13037-019-0190-8

Clear, Rich Sound. Understanding the Research Supporting Phonak Audeo Marvel

Phonak Marvel is the next generation of ground breaking hearing technology developed by Phonak. Built on the SWORD™ chip, Audeo Marvel offers unmatched hearing performance with AutoSense OS™ 3.0, the best first fit ever achieved by Phonak, and reduced listening effort when hearing gets tough. This course will provided a deeper overview of each research study supporting Phonak Audeo Marvel.

from #Audiology via ola Kala on Inoreader http://bit.ly/2V4RP6u
via IFTTT

Vanderbilt Audiology Journal Club: A Vestibular Update

This edition of the Vanderbilt Audiology Journal Club will cover recent articles and publications on vestibular topics presented by Gary Jacobson, PhD, Richard A. Roberts, PhD and Kelsey Hatton, AuD.

from #Audiology via ola Kala on Inoreader http://bit.ly/2EgsCAn
via IFTTT

Clear, Rich Sound. Understanding the Research Supporting Phonak Audeo Marvel

Phonak Marvel is the next generation of ground breaking hearing technology developed by Phonak. Built on the SWORD™ chip, Audeo Marvel offers unmatched hearing performance with AutoSense OS™ 3.0, the best first fit ever achieved by Phonak, and reduced listening effort when hearing gets tough. This course will provided a deeper overview of each research study supporting Phonak Audeo Marvel.

from #Audiology via ola Kala on Inoreader http://bit.ly/2V4RP6u
via IFTTT

Vanderbilt Audiology Journal Club: A Vestibular Update

This edition of the Vanderbilt Audiology Journal Club will cover recent articles and publications on vestibular topics presented by Gary Jacobson, PhD, Richard A. Roberts, PhD and Kelsey Hatton, AuD.

from #Audiology via ola Kala on Inoreader http://bit.ly/2EgsCAn
via IFTTT

Clear, Rich Sound. Understanding the Research Supporting Phonak Audeo Marvel

Phonak Marvel is the next generation of ground breaking hearing technology developed by Phonak. Built on the SWORD™ chip, Audeo Marvel offers unmatched hearing performance with AutoSense OS™ 3.0, the best first fit ever achieved by Phonak, and reduced listening effort when hearing gets tough. This course will provided a deeper overview of each research study supporting Phonak Audeo Marvel.

from #Audiology via ola Kala on Inoreader http://bit.ly/2V4RP6u

Vanderbilt Audiology Journal Club: A Vestibular Update

This edition of the Vanderbilt Audiology Journal Club will cover recent articles and publications on vestibular topics presented by Gary Jacobson, PhD, Richard A. Roberts, PhD and Kelsey Hatton, AuD.

from #Audiology via ola Kala on Inoreader http://bit.ly/2EgsCAn